T1	PROC 159 183	Estudio de un solo grupo
T2	DISO 96 99	RAI
T3	DISO 310 350	esclerosis múltiple remitente-recurrente
#1	AnnotatorNotes T3	C0751967; Multiple Sclerosis, Relapsing-Remitting; Disease or Syndrome
T4	DISO 404 444	Esclerosis múltiple remitente-recurrente
#2	AnnotatorNotes T4	C0751967; Multiple Sclerosis, Relapsing-Remitting; Disease or Syndrome
T5	PROC 516 527	tratamiento
#3	AnnotatorNotes T5	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T6	CHEM 532 540	LEMTRADA
#4	AnnotatorNotes T6	C3860145; Lemtrada; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T7	PROC 805 828	tratamiento sintomático
#5	AnnotatorNotes T7	C2146147; treat symptoms; Therapeutic or Preventive Procedure
T8	PROC 1040 1063	estudio de intervención
#6	AnnotatorNotes T8	C3274035; Interventional Study; Research Activity
T9	CHEM 976 984	LEMTRADA
#7	AnnotatorNotes T9	C3860145; Lemtrada; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T10	DISO 60 94	reacciones asociadas a la infusión
#8	AnnotatorNotes T10	C0948715; Infusion-Related Reaction; Pathologic Function
T11	PROC 86 94	infusión
#9	AnnotatorNotes T11	C0574032; Infusion procedures; Therapeutic or Preventive Procedure
T12	PROC 221 229	infusión
#10	AnnotatorNotes T12	C0574032; Infusion procedures; Therapeutic or Preventive Procedure
T13	DISO 252 286	reacciones asociadas a la infusión
#11	AnnotatorNotes T13	C0948715; Infusion-Related Reaction; Pathologic Function
T14	PROC 278 286	infusión
#12	AnnotatorNotes T14	C0574032; Infusion procedures; Therapeutic or Preventive Procedure
T15	PROC 696 710	administración
#13	AnnotatorNotes T15	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T16	PROC 881 891	infusiones
#14	AnnotatorNotes T16	C0574032; Infusion procedures; Therapeutic or Preventive Procedure
T17	DISO 352 356	EMRR
T18	CHEM 714 722	LEMTRADA
#15	AnnotatorNotes T18	C3860145; Lemtrada; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T19	PROC 604 628	consentimiento informado
#16	AnnotatorNotes T19	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T20	DISO 496 500	EMRR
T21	CHEM 371 379	LEMTRADA
#17	AnnotatorNotes T21	C3860145; Lemtrada; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T22	CHEM 127 135	LEMTRADA
#18	AnnotatorNotes T22	C3860145; Lemtrada; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T23	DISO 288 291	RAI
T24	PROC 358 366	tratados
#19	AnnotatorNotes T24	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T25	PROC 114 122	tratados
#20	AnnotatorNotes T25	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T26	PROC 951 959	tratados
#21	AnnotatorNotes T26	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T27	Date 13 17	2014
T29	LIVB 104 113	pacientes
#22	AnnotatorNotes T29	C0030705; Patients; Patient or Disabled Group
T33	LIVB 296 305	pacientes
#23	AnnotatorNotes T33	C0030705; Patients; Patient or Disabled Group
T35	LIVB 474 491	Pacientes adultos
#24	AnnotatorNotes T35	C0030705; Patients; Patient or Disabled Group + C0001675; Adult; Age Group
T36	LIVB 941 950	Pacientes
#25	AnnotatorNotes T36	C0030705; Patients; Patient or Disabled Group
T37	LIVB 987 996	Pacientes
#26	AnnotatorNotes T37	C0030705; Patients; Patient or Disabled Group
T38	Date 1020 1031	actualmente
A1	Population_data T35 Age
A2	Assertion T15 Contraindicated
A3	Assertion T18 Contraindicated
A4	Assertion T7 Contraindicated
A5	Status T26 History_of
A6	Status T9 History_of
#27	AnnotatorNotes T2	C0948715; Infusion-Related Reaction; Pathologic Function
#28	AnnotatorNotes T23	C0948715; Infusion-Related Reaction; Pathologic Function
#29	AnnotatorNotes T17	C0948715; Infusion-Related Reaction; Pathologic Function
#30	AnnotatorNotes T20	C0948715; Infusion-Related Reaction; Pathologic Function
#31	AnnotatorNotes T1	C2826346; Single Group Study; Research Activity 
#32	AnnotatorNotes T38	C0521116; Current (present time); Temporal Concept 
R1	Before Arg1:T11 Arg2:T10	
R2	Before Arg1:T11 Arg2:T2	
R3	Used_for Arg1:T22 Arg2:T25	
R4	Used_for Arg1:T22 Arg2:T11	
R5	Experiences Arg1:T29 Arg2:T10	
R6	Experiences Arg1:T29 Arg2:T2	
R7	Experiences Arg1:T29 Arg2:T25	
R8	Experiences Arg1:T29 Arg2:T22	
R9	Used_for Arg1:T21 Arg2:T24	
R10	Used_for Arg1:T21 Arg2:T12	
R11	Experiences Arg1:T33 Arg2:T12	
R12	Experiences Arg1:T33 Arg2:T13	
R13	Experiences Arg1:T33 Arg2:T14	
R14	Experiences Arg1:T29 Arg2:T11	
R15	Experiences Arg1:T33 Arg2:T23	
R16	Before Arg1:T14 Arg2:T13	
R17	Before Arg1:T14 Arg2:T23	
R18	Before Arg1:T12 Arg2:T13	
R19	Experiences Arg1:T33 Arg2:T3	
R20	Experiences Arg1:T33 Arg2:T17	
R21	Experiences Arg1:T33 Arg2:T24	
R22	Experiences Arg1:T35 Arg2:T20	
R23	Experiences Arg1:T35 Arg2:T5	
R24	Used_for Arg1:T6 Arg2:T5	
R25	Used_for Arg1:T18 Arg2:T15	
R26	Overlap Arg1:T7 Arg2:T16	
R27	Experiences Arg1:T36 Arg2:T26	
R28	Used_for Arg1:T9 Arg2:T26	
T28	Observation 1007 1063	participando actualmente en otro estudio de intervención
R29	Overlap Arg1:T28 Arg2:T38	
R30	Overlap Arg1:T8 Arg2:T38	
R32	Used_for Arg1:T21 Arg2:T14	
A7	Experiencer T29 Patient
A8	Experiencer T33 Patient
A9	Experiencer T35 Patient
A10	Experiencer T36 Patient
A11	Experiencer T37 Patient
